Nevada 2025 Regular Session

Nevada Assembly Bill AB382

Introduced

3/10/25

Refer

3/10/25

Failed

4/12/25

Caption

Revises provisions relating to health insurance coverage for biomarker testing. (BDR 57-913)

Latest NV AB382 Activity

View All Events: NV 2025 Regular Session AB382

Companion Bills

No companion bills found.

Previously Filed As

NV AB155

Establishes provisions relating to biomarker testing. (BDR 40-305)

NV SB330

Revises provisions related to health care. (BDR 57-161)

NV SB132

Revises provisions relating to insurance coverage for living organ donors. (BDR 57-551)

NV SB352

Revises provisions relating to prescription drugs. (BDR 57-134)

NV SB57

Revises provisions relating to insurance. (BDR 57-272)

NV SB267

Establishes provisions relating to insurance coverage of mental health services. (BDR 57-1020)

NV AB383

Revises provisions relating to health care. (BDR 40-116)

NV SB194

Revises provisions relating to step therapy protocols. (BDR 57-885)

NV SB439

Revises provisions relating to communicable diseases. (BDR 40-987)

NV SB393

Revises provisions related to dental insurance. (BDR 57-101)

Similar Bills

NV AB155

Establishes provisions relating to biomarker testing. (BDR 40-305)

CA SB496

Biomarker testing.

CA SB912

Biomarker testing.

DE SB120

An Act To Amend Titles 18, 29, And 31 Of The Delaware Code Relating To Health Insurance.

ME LD1577

An Act to Require Health Insurance Coverage for Biomarker Testing

NJ A4163

Requires health insurers to provide coverage for biomarker precision medical testing.

NJ S3098

Requires health insurers to provide coverage for biomarker precision medical testing.

NM HB73

Biomarker Testing Insurance Requirements